Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.
Messina C, Catalano M, Roviello G, Gandini A, Maruzzo M, De Giorgi U, Pedrazzoli P, Sbrana A, Zucal PA, Masini C, Naglieri E, Procopio G, Milella M, Catalano F, Fratino L, Pipitone S, Ricotta R, Panni S, Mollica V, Soraru M, Prati V, Atzori F, Di Napoli M, Messina M, Morelli F, Prati G, Nole F, Malgeri A, Tudini M, Vignani F, Cavo A, Signori A, Banna GL, Rescigno P, Buti S, Rebuzzi SE, Fornarini G. Messina C, et al. Among authors: pedrazzoli p. Cancer Immunol Immunother. 2024 Jul 2;73(9):161. doi: 10.1007/s00262-024-03741-2. Cancer Immunol Immunother. 2024. PMID: 38954006 Free PMC article.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK; CLEAR Trial Investigators. Motzer RJ, et al. J Clin Oncol. 2024 Apr 10;42(11):1222-1228. doi: 10.1200/JCO.23.01569. Epub 2024 Jan 16. J Clin Oncol. 2024. PMID: 38227898 Free PMC article. Clinical Trial.
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.
International Prognostic Factors Study Group; Lorch A, Beyer J, Bascoul-Mollevi C, Kramar A, Einhorn LH, Necchi A, Massard C, De Giorgi U, Fléchon A, Margolin KA, Lotz JP, Germa Lluch JR, Powles T, Kollmannsberger CK. International Prognostic Factors Study Group, et al. J Clin Oncol. 2010 Nov 20;28(33):4906-11. doi: 10.1200/JCO.2009.26.8128. Epub 2010 Oct 18. J Clin Oncol. 2010. PMID: 20956623
Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey.
Comoli P, Pentheroudakis G, Ruggeri A, Koehl U, Lordick F, Mooyaart JE, Hoogenboom JD, Urbano-Ispizua A, Peters S, Kuball J, Kröger N, Sureda A, Chabannon C, Haanen J, Pedrazzoli P; EBMT Cellular Therapy & Immunobiology Working Party; European Society of Medical Oncology. Comoli P, et al. Among authors: pedrazzoli p. Ann Oncol. 2024 Apr;35(4):404-406. doi: 10.1016/j.annonc.2023.12.009. Epub 2023 Dec 23. Ann Oncol. 2024. PMID: 38145867 No abstract available.
Harnessing tumor metabolism during cancer treatment: A narrative review of emerging dietary approaches.
Silvestris N, Aprile G, Tessitore D, Mentrasti G, Cristina Petrella M, Speranza D, Casirati A, Caccialanza R, Cinieri S, Pedrazzoli P; Italian Intersociety Working Group for Nutritional Support in Cancer Patients. Silvestris N, et al. Among authors: pedrazzoli p. Crit Rev Oncol Hematol. 2024 Nov 22;206:104571. doi: 10.1016/j.critrevonc.2024.104571. Online ahead of print. Crit Rev Oncol Hematol. 2024. PMID: 39581244 Review.
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems.
Jacobs F, D'Amico S, Zazzetti E, Gaudio M, Benvenuti C, Saltalamacchia G, Gerosa R, Gentile D, Lasagna A, Pedrazzoli P, Tinterri C, Santoro A, De Sanctis R, Porta MD, Zambelli A. Jacobs F, et al. Among authors: pedrazzoli p. Digit Health. 2024 Nov 3;10:20552076241288821. doi: 10.1177/20552076241288821. eCollection 2024 Jan-Dec. Digit Health. 2024. PMID: 39502478 Free PMC article. Review.
Erratum: Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers.
Albiñana CB, Pallocca M, Fenton H, Sopwith W, Eden CV, Akre O, Auranen A, Bocquet F, Borges M, Calvo E, Corkett J, Di Cosimo S, Gentili N, Guérin J, Jor S, Kazda T, Kolar A, Kuschel T, Lostes MJ, Paratore C, Pedrazzoli P, Petrovic M, Raid J, Roche M, Schatz C, Thonnard J, Tonon G, Traverso A, Wolf A, Zedan AH, Mahon P. Albiñana CB, et al. Among authors: pedrazzoli p. Appl Clin Inform. 2024 Aug;15(4):e1. doi: 10.1055/s-0044-1792139. Epub 2024 Nov 4. Appl Clin Inform. 2024. PMID: 39496321 Free article. No abstract available.
351 results